WebOct 26, 2024 · Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. … WebJun 23, 2024 · Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana®. Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for:
Brovana Inhalation: Uses, Side Effects, Interactions, …
http://ronstoppable.github.io/hcp/patientTypes/index.html WebBrovana Prices, Coupons and Patient Assistance Programs. Brovana (arformoterol) is a member of the adrenergic bronchodilators drug class and is commonly used for COPD - Maintenance. The cost for Brovana inhalation solution (15 mcg/2 mL) is around $602 for a supply of 60 milliliters, depending on the pharmacy you visit. Quoted prices are for ... david brown wabash national
Lupin Expands US Inhalation Business With Two Sunovion Brands
WebSep 2024 - Apr 20241 year 8 months. DC, MD, OH, KY, VA, NC, SC, GA: Created and led a team of 8 Nebulization Account Specialists promoting Brovana and Lonhala Magnair by building networks of ... WebNov 27, 2016 · Marlborough, Mass.-based Sunovion Pharmaceuticals Inc., a unit of Osaka, Japan-based Dainippon Sumitomo Pharma Co. Ltd., received approval for its respiratory drug Brovana (generic name: arformoterol tartrate) by the U.S. Food and Drug Administration (FDA) on Oct. 6, 2006. WebOct 20, 2024 · Brovana ® was developed by Sunovion and launched in the U.S. in 2007. About Xopenex HFA ® Inhalation Aerosol Xopenex HFA ® Inhalation Aerosol, formulated for use with a metered dose inhaler, is a short-acting beta2-adrenergic agonist indicated for the treatment or prevention of bronchospasm in patients with reversible obstructive airway … gash the gnoll 5e